The immunopathogenesis of hepatitis C virus infection

Clinics in Liver Disease

Volumn 5, Issue 4, 2001, Pages 931-953

  Nelson, David R ^a  

^a UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

POLYCLONAL ANTIBODY; VIRUS ANTIBODY;

CELLULAR IMMUNITY; CYTOKINE PRODUCTION; HEPATITIS C; HUMAN; HUMORAL IMMUNITY; IMMUNE SYSTEM; IMMUNOPATHOGENESIS; LIVER CELL DAMAGE; NONHUMAN; PERSISTENT INFECTION; REVIEW; T LYMPHOCYTE; VIRUS CELL INTERACTION;

EID: 0034777985     PISSN: 10893261     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1089-3261(05)70202-6     Document Type: Article

References (111)

1. Bystander activation by cytokines of intrahepatic T cells in chronic viral hepatitis
2. Helminth infection results in decreased virus-specific CD8+ cytotoxic T cell and Th1 cytokine response as well as delayed virus clearance
3. Adenosine acts as an endogenous modulator of IL-2-dependent proliferation of cytotoxic T lymphocytes
4. Clinical and histological features of a group of patients with sporadic non-A, non-B hepatitis
5. Viral persistence, antibody to E1 and E2, and hypervariable region 1 sequence stability in hepatitis C virus-inoculated chimpanzees
6. Different cytokine profiles of intrahepatic T cells in chronic hepatitis B and hepatitis C virus infections
7. Role of early cytokines, including alpha and beta interferons, in innate and adaptive immune responses to viral infections
8. Intravenous immunoglobulin prophylaxis causing liver damage in 16 of 77 patients with hypogammaglobulinaemia or IgG subclass deficiency
9. T-lymphocyte response to hepatitis C virus in different clinical courses of infection
10. Biology of cloned cytotoxic T lymphocytes specific for lymphocytic choriomeningitis virus: Clearance of virus in vivo
11. Immunoregulatory cytokines in hepatitis C virus infection: Pre- and post treatment with interferon alfa
12. Cytotoxic T lymphocyte response to hepatitis C virus-derived peptides containing the HLA A2.1 binding motif
13. Increased mortality following CMV infection in patients transplanted for HCV: Results of the NIDDK liver transplantation database
14. Hepatitis B virus transgenic mice: Models of viral immunobiology and pathogenesis
15. Isolation of a cDNA clone derived from a blood borne non-A, non-B hepatitis genome
16. The Th1-Th2 hypothesis of HIV infection: New insights
17. Analysis of a successful immune response against hepatitis C virus
18. Hepatitis C virus-specific T-cell reactivity during interferon and ribavirin treatment in chronic hepatitis C
19. Antibodies to hepatitis C virus in essential mixed cryoglobulinemia
20. IL-10 and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression
21. Classification of chronic hepatitis: Diagnosis, grading, and staging
22. Clinical and histologic patterns of early graft failure due to recurrent hepatitis C in four patients after liver transplantation
23. Histological observations in human non-A, non-B hepatitis
24. Immunodominant CD4+ T-cell epitope within nonstructural protein 3 in acute hepatitis C virus infection
25. Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C infection
26. Immunodominant CD4+ T-cell epitope within nonstructural protein 3 in acute hepatitis C virus infection
27. Treatment of chronic hepatitis C with recombinant human interferon-2a: Results of a randomized controlled clinical trial
28. Interleukin-10 promoter polymorphism predicts initial response of chronic hepatitis C to interferon alfa
29. Hepatitis C virus-specific CTL responses in the liver of the chimpanzees with acute and chronic hepatitis C
30. Requirements for CD1d recognition by human invariant vα24+ CD4- CD8- T cells
31. Hepatic expression of c-Fas and apoptosis in chronic hepatitis C virus infection
32. HLA class II genes determine the natural variance of hepatitis C viral load
33. Lack of protective immunity against reinfection with hepatitis C virus
34. Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization
35. IL-10 acts on the antigen presenting cell to inhibit cytokine production by Th1 cells
36. Vascular adhesion molecule expression in viral chronic hepatitis: Evidence of neoangiogenesis in portal tracts
37. Recurrence of hepatitis C virus after loss of HCV-specific CD4+ T-cell response in acute hepatitis C
38. Regulation of monocyte interleukin-12 production by acute alcohol: A role for inhibition by interleukin-10
39. Association of hepatitis C virus-specific CD8+ T cells with viral clearance in acute hepatitis C
40. Noncytopathic clearance of lymphocyte choriomeningitis virus from the hepatocyte
41. Intracellular inactivation of hepatitis B virus by cytotoxic T lymphocytes
42. Association of HLA and TAP2 gene polymorphisms on the clinical outcome of HCV infection
43. Quantitative analysis of hepatitis C virus-specific CD8+ T cells in peripheral blood and liver using peptide-MHC tetramers
44. Immunohistochemical detection of Fas antigen in liver tissue of patients with chronic hepatitis C
45. Cytotoxic T lymphocyte response and viral load in hepatitis C virus infection
46. Mapping of immunodominant CD4+ T lymphocyte epitopes of hepatitis C virus antigens and their relevance during the course of chronic infection
47. Enhanced apoptosis of activated T cells induced by hepatocytes expressing HCV structural proteins
48. Increase in CD5+ B-cells in juvenile rheumatoid arthritis. Relationship to IgM rheumatoid factor expression and disease activity
49. Fas and perforin pathways as major mechanisms of T-cell mediated cytotoxicity
50. Transgenic expression of hepatitis C virus structural proteins in the mouse
51. A helper T-cell antigen enhances generation of hepatitis C virus-specific cytotoxic T lymphocytes in vitro
52. HLA B44-restricted cytotoxic T lymphocytes recognizing an epitope on hepatitis C virus nucleocapsid protein
53. Intrahepatic cytotoxic T lymphocytes specific for hepatitis C virus in persons with chronic hepatitis
54. Hepatitis C virus-specific cytotoxic T lymphocytes recognize epitopes in the core and envelope proteins of HCV
55. Increased frequency of HLA DR13 in hepatitis C virus carriers with persistently normal ALT levels
56. Influence of HLA haplotypes on the clinical courses of individuals infected with hepatitis C virus
57. Hepatitis C virus in multiple episodes of acute hepatitis in polytransfused thalassemic children
58. Cellular immunity to hepatitis C virus core protein and the response to interferon in patients with chronic hepatitis C
59. Immunoglobulin M and A in chronic hepatitis C virus infection
60. High level expression of hepatitis B viral antigen in fibrosing cholestatic hepatitis; evidence that HBV may be cytopathic in liver grafts
61. TH1 and TH2 cytokines on response of HCV infection to combined alpha interferon-ribavirin therapy
62. T and B cell responses to different hepatitis C virus antigens in patients with chronic hepatitis C infection and healthy anti-HCV seropositives
63. Analysis of successful immune response in persons infected with hepatitis C
64. Blunted anti-inflammatory response to adenosine in alcoholic cirrhosis
65. Cholestatic hepatitis leading to hepatic failure in a patient with organ-transmitted hepatitis C virus infection
66. The role of cellular immune response in chronic HCV infection
67. The viral clearance in interferon-treated chronic hepatitis C is associated with increased cytotoxic T cell frequencies
68. Compartmentalization of T lymphocytes to the site of disease: Intrahepatic CD4+ T-cell-specific for the protein NS4 of hepatitis C virus in patients with chronic hepatitis C
69. Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response
70. Th1 and Th2 cells: Different patterns of lymphokine secretion lead to different functional properties
71. IgM antibody to a hepatitis C virus core peptide (CP14) for monitoring activity of liver disease in patients with acute or chronic hepatitis C
72. Progressive liver injury in chronic hepatitis C infection correlates with increased intrahepatic expression of Th1-associated cytokines
73. Interleukin 10 treatment reduces fibrosis in patients with chronic hepatitis C: A pilot trial in interferon nonresponders
74. Activation of tumor necrosis system in chronic hepatitis C virus infection
75. Intrahepatic HCV-specific CTL activity and response to interferon therapy in chronic HCV
76. The effect of anti-interleukin-2 receptor therapy on the course of hepatitis C recurrence after liver transplantation
77. Serum cytokine profiles in patients with chronic HCV: Effect of interferon treatment
78. Dynamics of intra-hepatic lymphocytes in chronic hepatitis C: Enrichment for V alpha 24 T cells and rapid elimination of effector cells by apoptosis
79. Intrahepatic lymphocyte subpopulations and HLA class I antigen expression by hepatocytes in chronic hepatitis C
80. Apoptosis and hepatobiliary disease
81. Extrahepatic immunologic manifestations in chronic hepatitis C and hepatitis C virus serotypes
82. HLA-DR5 antigen. A genetic factor influencing the outcome of hepatitis C virus infection?
83. Effect of alcohol consumption on serum hepatitis C virus RNA and histological lesions in chronic hepatitis C
84. Interferons and their actions
85. Lymphocyte subsets in HCV-positive chronic liver disease
86. Peptide immunogen mimicry of putative E1 glycoprotein-specific epitopes in hepatitis C virus
87. Acute hepatitis C structural gene sequences as predictors of persistent viremia: Hypervariable region 1 as a decoy
88. Differential cytotoxic T-lymphocyte responsiveness to the hepatitis B and C viruses in chronically infected patients
89. Cytomegalovirus viremia: Risk factor for allograft cirrhosis following liver transplantation for hepatitis C
90. Association of multispecific CD4+ response to hepatitis C and severity of recurrence after liver transplantation
91. Sensitization to Fas-mediated apoptosis by hepatitis C virus core protein
92. Liver-derived hepatitis C virus-specific CD4+ T cells recognize multiple HCV epitopes and produce interferon gamma
93. Cytokine profile of liver- and blood-derived nonspecific T cells after liver transplantation: T helper cells type 1/0 lymphokines dominate in recurrent hepatitis C virus infection and rejection
94. Severe recurrent cholestatic hepatitis C following orthotopic liver transplantation
95. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions
96. Severe or multiple rejection episodes are associated with early recurrence of hepatitis C after orthotopic liver transplantation
97. Hepatitis C serotypes in nonalcoholic and alcoholic patients
98. A natural killer cell granule protein that induces DNA fragmentation and apoptosis
99. Function and specificity of T-cell subsets in the mouse
100. Regulation of human monocyte functions by acute ethanol treatment: Decreased tumor necrosis factor-alpha, interleukin-1 beta and elevated interleukin-1 beta and elevated interleukin-10, and transforming growth factor-beta production
101. Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C
102. Influence of MHC class II genotype on outcome of infection with hepatitis C virus
103. Viral subversion of the immune system
104. Immune response to a hepatitis C nonstructural protein in chronic hepatitis C virus infection
105. Detection of type 2-like T-helper cells in hepatitis C virus infection: Implications for hepatitis C virus chronicity
106. A histopathological study of alcoholics with chronic HCV infection: Comparison with chronic hepatitis C and alcoholic liver disease
107. Life, activation and death of intrahepatic lymphocytes in chronic hepatitis C
108. Hepatitis C virus NS3 specific cytotoxic T cells can be induced by influenza A virus infection
109. Ultrastructural changes in cells expressing HCV structural proteins - Implications on pathogenesis
110. Epitope mapping of antibodies directed against hypervariable region 1 in acute self-limiting and chronic infections due to hepatitis C virus
111. Early antibody response against hypervariable region 1 is associated with acute self-limiting infections of hepatitis C virus